It is estimated that more than 4 million people have AHD—defined as having a CD4 <200 cells μl−1 or a WHO stage 3 or 4 disease—and each year more than 600 000 of these are expected to die [3,4]. This evidence concerns the gene CD4 and mitochondrial DNA depletion syndrome 4a.